Koninklijke Philips (PHG) Cash from Discontinued Operations (2009 - 2025)

Koninklijke Philips (PHG) recorded quarterly Cash from Discontinued Operations of 11640435.15 in Q4 2025, little changed quarter-over-quarter from 11690550.91 in Q3 2025, and up 16.21% on a YoY basis from 10017062.97 in Q4 2024.

Koninklijke Philips (PHG) Cash from Discontinued Operations (2009 - 2025) Analysis & Trends

Koninklijke Philips' Cash from Discontinued Operations history runs 17 years deep, the most recent figure standing at 11640435.15 for Q4 2025.

  • In Q4 2025, Cash from Discontinued Operations rose 16.21% year-over-year to 11640435.15; the TTM figure through Dec 2025 stood at 45169427.34 (up 34.85% YoY), while the FY2024 annual figure was 13891740.2, down 110.5% from the prior year.
  • Cash from Discontinued Operations was 11640435.15 for Q4 2025 at Koninklijke Philips, roughly flat from 11690550.91 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 4552049064.24 in Q3 2021 to a low of 61889287.92 in Q2 2022.
  • Historically, Cash from Discontinued Operations has averaged 424390806.45 across 5 years, with a median of 10919220.64 in 2025.
  • The sharpest annual moves came in 2021 and 2024: Cash from Discontinued Operations jumped 2431.08% in 2021, then plunged 330.16% in 2024.
  • A 5-year view of Cash from Discontinued Operations shows it stood at 3892933146.71 in 2021, then slumped by 100.31% to 12242968.38 in 2022, then jumped by 275.76% to 21518798.18 in 2023, then sank by 164.56% to 13891740.2 in 2024, then increased by 16.21% to 11640435.15 in 2025.
  • The last three Cash from Discontinued Operations figures came in at 11640435.15 (Q4 2025), 11690550.91 (Q3 2025), and 11319596.88 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -11.64 Mn
Dec 31, 2025 -11.64 Mn
Sep 30, 2025 -11.69 Mn
Sep 30, 2025 -11.69 Mn
Jun 30, 2025 -11.32 Mn
Jun 30, 2025 -11.32 Mn
Mar 31, 2025 -10.52 Mn
Mar 31, 2025 -10.52 Mn
Dec 31, 2024 -13.89 Mn
Dec 31, 2024 -13.89 Mn
Sep 30, 2024 -18.67 Mn
Sep 30, 2024 -18.67 Mn
Jun 30, 2024 -18.31 Mn
Jun 30, 2024 -18.31 Mn
Mar 31, 2024 -18.47 Mn
Mar 31, 2024 -18.47 Mn
Dec 31, 2023 21.52 Mn
Dec 31, 2023 21.52 Mn
Sep 30, 2023 87.09 Mn
Sep 30, 2023 87.09 Mn